Загрузка...
Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
BACKGROUND: The addition of hypoxia modifiers carbogen and nicotinamide (CON) to radiotherapy (RT) improved overall survival (OS) in bladder cancer patients in the BCON phase III clinical trial. We investigate whether expression of hsa-miR-210 in BCON patient samples reflects hypoxia and predicts be...
Сохранить в:
| Опубликовано в: : | Br J Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4997544/ https://ncbi.nlm.nih.gov/pubmed/27441495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.218 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|